Company: PFSA
Filing Date: 2025-06-09
Form Type: 8-K
Source: 0001213900-25-052486
Chunk: 0

Company: Profusa, Inc.
Filing Date: 2025-06-09
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01 Other Events.

As previously announced, NorthView Acquisition
Corporation’s (the “ Company”) previously entered into that certain Merger Agreement and Plan of Reorganization, dated
as of November 7, 2022 (as amended by Amendment No. 1, dated September 12, 2023, Amendment No. 2, dated January 12, 2024, Amendment No.
3, dated March 4, 2024, Amendment No. 4, dated February 11, 2025, Amendment No. 5, dated April 2, 2025, and as may be further amended,
supplemented or otherwise modified from time to time, the “ Merger Agreement”), by and among the Company, NV Profusa Merger
Sub Inc., a Delaware corporation and a direct, wholly-owned subsidiary of NorthView, and Profusa, Inc., a California corporation. The
transactions contemplated by the Merger Agreement are referred to herein as the “ Business Combination.”

Additionally, as previously announced, in connection
with the transactions contemplated by the Merger Agreement (together, the “ Business Combination”) the Company entered into
a non-redemption agreement (the “ Non-Redemption Agreement”) with I-Bankers Securities, Inc. and Dawson James Securities,
Inc. (together, the “ Investors”), pursuant to which such Investors agreed that to the extent that redemptions in connection
with the vote to approve the Business Combination reduces the Company’s trust account balance below $1.25 million, the Investors
would offer such redeeming shareholders an opportunity to rescind the redemption of their shares and would instead purchase such shares.
The parties agreed that such purchases would be structured in compliance with the requirements of Rule 14e-5 under the Exchange
Act or would otherwise not constitute a tender offer pursuant to the Exchange Act, including the waiver of any redemption rights
on such purchased securities.

Pursuant to the Non-Redemption Agreement, the Investors purchased 100,000
shares of the Company’s common stock at a price of $12.51 from a hedge fund that owned less than 5% of the outstanding common stock
of the Company. The Non-Redemption Agreement may reduce the number of NorthView common stock redeemed in connection with the Company’s
Business Combination, and such reduction could alter the perception of the potential strength of the Business Combination. The purpose
of the Non-Redemption Agreement, and the purchases thereunder, is